The nephrostomy devices market size has grown strongly in recent years. It will grow from $1.3 billion in 2025 to $1.41 billion in 2026 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to rising prevalence of kidney stones, increasing incidence of urinary tract obstructions, growth in urological surgical procedures, expansion of hospital-based interventional radiology, increasing awareness of renal function preservation.
The nephrostomy devices market size is expected to see strong growth in the next few years. It will grow to $1.89 billion in 2030 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to growing burden of urological cancers, increasing adoption of minimally invasive urology procedures, rising geriatric population with renal disorders, expansion of ambulatory surgical centers, increasing demand for long-term urinary drainage solutions. Major trends in the forecast period include growing adoption of percutaneous nephrostomy procedures, rising demand for minimally invasive urinary drainage solutions, increasing use of hydrophilic and coated nephrostomy devices, expansion of image-guided nephrostomy interventions, growing focus on patient comfort and infection prevention.
The increasing incidence of kidney transplants is expected to drive the growth of the nephrostomy device market in the coming years. A kidney transplant is a surgical procedure in which a healthy kidney from a donor is implanted into a patient with kidney failure. The rise in kidney transplants is driven by the growing prevalence of chronic kidney disease and kidney failure, along with advancements in medical technology and transplant procedures. Nephrostomy devices support kidney transplants by providing a temporary means to drain urine directly from the kidneys when complications, such as urinary tract blockages, occur, ensuring proper kidney function and reducing the risk of infection or damage to the transplanted kidney during the critical post-transplant recovery period. For example, in January 2025, according to the Organ Procurement and Transplantation Network, a US-based non-profit organization, kidney transplants modestly increased to 27,759 in 2024, up 1.6% from 2023, while heart transplants remained nearly unchanged at 4,572 procedures in 2024 compared to 4,545 in 2023. Therefore, the rising incidence of kidney transplants is fueling the growth of the nephrostomy device market.
Leading companies in the nephrostomy devices market are focusing on developing advanced solutions, such as multi-layered catheter safety innovations, to replace conventional catheter stabilization methods. An advanced solution refers to technology that enhances patient safety by minimizing the risk of infections, accidental dislodgement, and discomfort. For example, in November 2025, Cathetrix Ltd., a US-based developer of smart catheter stabilization devices, launched Nephro-Safe, the world’s most advanced nephrostomy tube stabilizer, under its new subsidiary TubeX. This innovation replaces traditional stabilization methods by providing a dual-layer protection system, featuring a secure anchoring mechanism and smart anti-slide technology that prevents external forces from impacting the nephrostomy site. When integrated with Cathetrix’s Foley-Safe catheter stabilizer, it offers a three-layer protection system for Foley catheters, addressing fixation, movement absorption, and safe disconnection. These innovations enhance patient comfort, improve safety, and simplify catheter management for caregivers.
In October 2023, Laborie Medical Technologies Corp acquired Urotronic Inc, a move aimed at integrating innovative technologies that enhance interventional urology procedures into their portfolio. Urotronic Inc, a US-based medical device company specializing in nephrostomy devices, will contribute its expertise to Laborie's efforts in preserving and restoring human dignity through advanced medical technologies.
Major companies operating in the nephrostomy devices market are Becton Dickinson and Company, Boston Scientific Corporation, Olympus Corporation, Terumo Corporation, Coloplast Corp., B Braun Medical Inc., Cook Medical, Teleflex Incorporated, Merit Medical Systems, AngioDynamics, Argon Medical Devices, Well Lead Medical Co Ltd, Amecath, Medi-Globe GmbH, Troge Medical GmbH, Rocamed, Suru International Pvt Ltd, UroMed, Electramed Ltd, Urovision Urotech, Manfred Sauer UK, Surgimedik Healthcare India Pvt Ltd.
North America was the largest region in the nephrostomy devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nephrostomy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the nephrostomy devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the nephrostomy devices market by increasing costs of imported raw materials and components such as polymers, coatings, and specialized medical-grade tubing. These impacts are most pronounced in asia-pacific and north america, where manufacturers depend on global supply chains for guidewires, catheters, and drainage accessories. Elevated production costs have influenced pricing across hospitals and ambulatory surgical centers. On the positive side, tariffs have encouraged local manufacturing, supplier diversification, and strengthened regional production capabilities for urology devices.
The nephrostomy devices market research report is one of a series of new reports that provides nephrostomy devices market statistics, including nephrostomy devices industry global market size, regional shares, competitors with a nephrostomy devices market share, detailed nephrostomy devices market segments, market trends and opportunities, and any further data you may need to thrive in the nephrostomy devices industry. This nephrostomy devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Nephrostomy devices are medical tools utilized to establish and maintain an artificial passage between the kidney and the skin's surface, facilitating urine drainage. These devices play a crucial role in the management of conditions such as kidney stones, tumors, or strictures that obstruct urinary flow. They offer both temporary and long-term relief of symptoms while preserving kidney function.
The primary types of nephrostomy devices include guidewires, drainage tubes, nephrostomy catheters, sheath dilators, and others. Guidewires are slender, flexible wires that assist in guiding catheters or other medical instruments into position during nephrostomy procedures. They are employed in a range of applications including kidney diseases, urological cancers, benign prostatic hyperplasia (BPH), and various other medical procedures conducted by hospitals, clinics, ambulatory surgical centers (ASCs), and other end-users.
The nephrostomy devices market consists of sales of nephrostomy tubes, catheters, guidewires, dilators, sheaths, and drainage bags. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The nephrostomy devices market size is expected to see strong growth in the next few years. It will grow to $1.89 billion in 2030 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to growing burden of urological cancers, increasing adoption of minimally invasive urology procedures, rising geriatric population with renal disorders, expansion of ambulatory surgical centers, increasing demand for long-term urinary drainage solutions. Major trends in the forecast period include growing adoption of percutaneous nephrostomy procedures, rising demand for minimally invasive urinary drainage solutions, increasing use of hydrophilic and coated nephrostomy devices, expansion of image-guided nephrostomy interventions, growing focus on patient comfort and infection prevention.
The increasing incidence of kidney transplants is expected to drive the growth of the nephrostomy device market in the coming years. A kidney transplant is a surgical procedure in which a healthy kidney from a donor is implanted into a patient with kidney failure. The rise in kidney transplants is driven by the growing prevalence of chronic kidney disease and kidney failure, along with advancements in medical technology and transplant procedures. Nephrostomy devices support kidney transplants by providing a temporary means to drain urine directly from the kidneys when complications, such as urinary tract blockages, occur, ensuring proper kidney function and reducing the risk of infection or damage to the transplanted kidney during the critical post-transplant recovery period. For example, in January 2025, according to the Organ Procurement and Transplantation Network, a US-based non-profit organization, kidney transplants modestly increased to 27,759 in 2024, up 1.6% from 2023, while heart transplants remained nearly unchanged at 4,572 procedures in 2024 compared to 4,545 in 2023. Therefore, the rising incidence of kidney transplants is fueling the growth of the nephrostomy device market.
Leading companies in the nephrostomy devices market are focusing on developing advanced solutions, such as multi-layered catheter safety innovations, to replace conventional catheter stabilization methods. An advanced solution refers to technology that enhances patient safety by minimizing the risk of infections, accidental dislodgement, and discomfort. For example, in November 2025, Cathetrix Ltd., a US-based developer of smart catheter stabilization devices, launched Nephro-Safe, the world’s most advanced nephrostomy tube stabilizer, under its new subsidiary TubeX. This innovation replaces traditional stabilization methods by providing a dual-layer protection system, featuring a secure anchoring mechanism and smart anti-slide technology that prevents external forces from impacting the nephrostomy site. When integrated with Cathetrix’s Foley-Safe catheter stabilizer, it offers a three-layer protection system for Foley catheters, addressing fixation, movement absorption, and safe disconnection. These innovations enhance patient comfort, improve safety, and simplify catheter management for caregivers.
In October 2023, Laborie Medical Technologies Corp acquired Urotronic Inc, a move aimed at integrating innovative technologies that enhance interventional urology procedures into their portfolio. Urotronic Inc, a US-based medical device company specializing in nephrostomy devices, will contribute its expertise to Laborie's efforts in preserving and restoring human dignity through advanced medical technologies.
Major companies operating in the nephrostomy devices market are Becton Dickinson and Company, Boston Scientific Corporation, Olympus Corporation, Terumo Corporation, Coloplast Corp., B Braun Medical Inc., Cook Medical, Teleflex Incorporated, Merit Medical Systems, AngioDynamics, Argon Medical Devices, Well Lead Medical Co Ltd, Amecath, Medi-Globe GmbH, Troge Medical GmbH, Rocamed, Suru International Pvt Ltd, UroMed, Electramed Ltd, Urovision Urotech, Manfred Sauer UK, Surgimedik Healthcare India Pvt Ltd.
North America was the largest region in the nephrostomy devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nephrostomy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the nephrostomy devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the nephrostomy devices market by increasing costs of imported raw materials and components such as polymers, coatings, and specialized medical-grade tubing. These impacts are most pronounced in asia-pacific and north america, where manufacturers depend on global supply chains for guidewires, catheters, and drainage accessories. Elevated production costs have influenced pricing across hospitals and ambulatory surgical centers. On the positive side, tariffs have encouraged local manufacturing, supplier diversification, and strengthened regional production capabilities for urology devices.
The nephrostomy devices market research report is one of a series of new reports that provides nephrostomy devices market statistics, including nephrostomy devices industry global market size, regional shares, competitors with a nephrostomy devices market share, detailed nephrostomy devices market segments, market trends and opportunities, and any further data you may need to thrive in the nephrostomy devices industry. This nephrostomy devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Nephrostomy devices are medical tools utilized to establish and maintain an artificial passage between the kidney and the skin's surface, facilitating urine drainage. These devices play a crucial role in the management of conditions such as kidney stones, tumors, or strictures that obstruct urinary flow. They offer both temporary and long-term relief of symptoms while preserving kidney function.
The primary types of nephrostomy devices include guidewires, drainage tubes, nephrostomy catheters, sheath dilators, and others. Guidewires are slender, flexible wires that assist in guiding catheters or other medical instruments into position during nephrostomy procedures. They are employed in a range of applications including kidney diseases, urological cancers, benign prostatic hyperplasia (BPH), and various other medical procedures conducted by hospitals, clinics, ambulatory surgical centers (ASCs), and other end-users.
The nephrostomy devices market consists of sales of nephrostomy tubes, catheters, guidewires, dilators, sheaths, and drainage bags. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Nephrostomy Devices Market Characteristics
3. Nephrostomy Devices Market Supply Chain Analysis
4. Global Nephrostomy Devices Market Trends and Strategies
5. Nephrostomy Devices Market Analysis of End Use Industries
7. Global Nephrostomy Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Nephrostomy Devices Total Addressable Market (TAM) Analysis for the Market
9. Nephrostomy Devices Market Segmentation
10. Nephrostomy Devices Market Regional and Country Analysis
11. Asia-Pacific Nephrostomy Devices Market
12. China Nephrostomy Devices Market
13. India Nephrostomy Devices Market
14. Japan Nephrostomy Devices Market
15. Australia Nephrostomy Devices Market
16. Indonesia Nephrostomy Devices Market
17. South Korea Nephrostomy Devices Market
18. Taiwan Nephrostomy Devices Market
19. South East Asia Nephrostomy Devices Market
20. Western Europe Nephrostomy Devices Market
21. UK Nephrostomy Devices Market
22. Germany Nephrostomy Devices Market
23. France Nephrostomy Devices Market
24. Italy Nephrostomy Devices Market
25. Spain Nephrostomy Devices Market
26. Eastern Europe Nephrostomy Devices Market
27. Russia Nephrostomy Devices Market
28. North America Nephrostomy Devices Market
29. USA Nephrostomy Devices Market
30. Canada Nephrostomy Devices Market
31. South America Nephrostomy Devices Market
32. Brazil Nephrostomy Devices Market
33. Middle East Nephrostomy Devices Market
34. Africa Nephrostomy Devices Market
36. Nephrostomy Devices Market Competitive Landscape and Company Profiles
37. Nephrostomy Devices Market Other Major and Innovative Companies
40. Nephrostomy Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Nephrostomy Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses nephrostomy devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for nephrostomy devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The nephrostomy devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Guidewires; Drainage Tubes; Nephrostomy Catheters; Sheath Dilators; Other Products2) By Application: Kidney Diseases; Urological Cancer And Benign Prostatic Hyperplasia (BPH)
3) By End-Use: Hospitals; Clinics; Ambulatory Surgical Centers (ASCs); Other End-Users
Subsegments:
1) By Guidewires: Straight Guidewires; Hydrophilic Guidewires; Coated Guidewires2) By Drainage Tubes: Single-Lumen Drainage Tubes; Double-Lumen Drainage Tubes
3) By Nephrostomy Catheters: Percutaneous Nephrostomy Catheters; Suprapubic Nephrostomy Catheters
4) By Sheath Dilators: Standard Sheath Dilators; Hydrophilic Sheath Dilators
5) By Other Products: Nephrostomy Bags; Catheter Fixation Devices; Nephrostomy Kits
Companies Mentioned: Becton Dickinson and Company; Boston Scientific Corporation; Olympus Corporation; Terumo Corporation; Coloplast Corp.; B Braun Medical Inc.; Cook Medical; Teleflex Incorporated; Merit Medical Systems; AngioDynamics; Argon Medical Devices; Well Lead Medical Co Ltd; Amecath; Medi-Globe GmbH; Troge Medical GmbH; Rocamed; Suru International Pvt Ltd; UroMed; Electramed Ltd; Urovision Urotech; Manfred Sauer UK; Surgimedik Healthcare India Pvt Ltd
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Nephrostomy Devices market report include:- Becton Dickinson and Company
- Boston Scientific Corporation
- Olympus Corporation
- Terumo Corporation
- Coloplast Corp.
- B Braun Medical Inc.
- Cook Medical
- Teleflex Incorporated
- Merit Medical Systems
- AngioDynamics
- Argon Medical Devices
- Well Lead Medical Co Ltd
- Amecath
- Medi-Globe GmbH
- Troge Medical GmbH
- Rocamed
- Suru International Pvt Ltd
- UroMed
- Electramed Ltd
- Urovision Urotech
- Manfred Sauer UK
- Surgimedik Healthcare India Pvt Ltd
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.41 Billion |
| Forecasted Market Value ( USD | $ 1.89 Billion |
| Compound Annual Growth Rate | 7.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 23 |
